Clinical Trials in Houston

Showing 11101-11120 of 15,366 trials

LifeVest Post-CABG Registry

NCT01448005

This is a multi-center prospective registry of patients with an ejection fraction (EF) ≤ 35% following coronary artery bypass graft (CABG) surgery in order to test the hypothesis that wearable defibrillators (WD) will decrease overall mortality after discharge by decreasing arrhythmic death in this select population with high risk for sudden cardiac death (SCD). This is a pilot project to determine the feasibility of a larger-scale study.

Sudden Cardiac DeathVentricular FibrillationVentricular Tachycardia+2 more

Zoll Medical Corporation69 participantsStarted Feb 2011

Sacramento, California, United States • Atlanta, Georgia, United States • Takoma Park, Maryland, United States +2 more locations

TERMINATEDPhase 4< 1 mile

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

NCT00559988

The IMPACT Study will investigate the potential clinical benefit of the combined use of BIOTRONIK Home Monitoring (HM) technology and a predefined anticoagulation plan compared to conventional device evaluation and physician-directed anticoagulation in patients with implanted dual-chamber defibrillators or cardiac resynchronization therapy devices.

Atrial FibrillationAtrial FlutterStroke+2 more

Biotronik, Inc.2,718 participantsStarted Feb 2008

Phoenix, Arizona, United States • Scottsdale, Arizona, United States • Anaheim, California, United States +77 more locations

LifeVest Post-CABG Registry

Combined Use of BIOTRONIK Home Monitoring and Predefined Anticoagulation to Reduce Stroke Risk

Find Trials by Condition in Houston

Study Evaluating Inotuzumab Ozogamicin (CMC-544) Plus Rituximab In Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Phase III Study Comparing Efficacy and Safety of AFOLIA vs Gonal-f® RFF in Women (35 to 42) Undergoing IVF

Rituximab and GM-CSF in Treating Patients With Newly Diagnosed Follicular B-Cell Lymphoma

DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

Extension Phase of the Chronicle® Offers Management to Patients With Advanced Signs & Symptoms of Heart Failure Study

Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/Glibenclamide

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Iressa Study in Patients With Salivary Gland Cancer

Acetaminophen Biomarkers

Treatment for Aggression and Agitation in Patients With Alzheimer's Disease

AMG 386 (Trebananib) in Ovarian Cancer (TRINOVA-2)

Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM)

Low Field Magnetic Stimulation (LFMS) in Subjects With Treatment-Resistant Depression (TRD)

Efficacy and Safety of Riociguat in Patients With Symptomatic Pulmonary Hypertension (PH) Associated With Idiopathic Interstitial Pneumonias (IIP)

Inactivated Influenza Via Jet Injection

Peri-orbital and Peri-oral Wrinkle Reduction Trial

A Study of the Ulthera® System for the Treatment of Axillary Hyperhidrosis

Long-term Efficacy and Safety of Repeated Ofatumumab Treatment Courses in RA Patients Who Previously Received Ofatumumab or Placebo in Trial Hx-CD20-403